Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
101	101 Tandem Diabetes Care TNDM $1.04B	85% upside 7 price targets	0
102	102 Revolution Medicines RVMD $7.08B	85% upside 5 price targets	0
103	103 Waldencast WALD $312M	84% upside 3 price targets	0
104	104 Holley HLLY $258M	83% upside 4 price targets	0
105	105 Enliven Therapeutics ELVN $1.32B	83% upside 4 price targets	0
106	106 Wave Life Sciences WVE $1.2B	82% upside 3 price targets	0
107	BBNX 107 Beta Bionics, Inc. Common Stock BBNX $549M	82% upside 4 price targets	0
108	108 Disc Medicine IRON $1.97B	81% upside 4 price targets	0
109	109 ArriVent BioPharma AVBP $794M	80% upside 6 price targets	0
110	110 Legend Biotech LEGN $7.17B	80% upside 6 price targets	0
111	111 Phathom Pharmaceuticals PHAT $641M	79% upside 5 price targets	0
112	112 Neuropace NPCE $312M	79% upside 3 price targets	0
113	113 Endava DAVA $816M	78% upside 5 price targets	0
114	114 Arvinas ARVN $569M	76% upside 13 price targets	0
115	115 Tarsus Pharmaceuticals TARS $1.65B	76% upside 3 price targets	0
116	116 SoundThinking SSTI $168M	76% upside 3 price targets	0
117	117 Merus MRUS $4.06B	76% upside 3 price targets	0
118	118 Criteo CRTO $1.26B	74% upside 8 price targets	0
119	119 AtriCure ATRC $1.52B	74% upside 4 price targets	0
120	120 indie Semiconductor INDI $750M	73% upside 3 price targets	0
121	121 NovoCure NVCR $1.96B	72% upside 3 price targets	0
122	122 QuinStreet QNST $875M	71% upside 3 price targets	0
123	123 Zeta Global ZETA $3.3B	71% upside 9 price targets	0
124	124 KalVista Pharmaceuticals KALV $722M	70% upside 3 price targets	0
125	125 CorMedix CRMD $835M	69% upside 3 price targets	0

1

34567

64